Skip to content

Author

S. Sundersingh

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognostic significance of end-of-induction measurable residual disease below 0.01% in pediatric B-lineage acute lymphoblastic leukemia.

End-of-induction measurable residual disease (EOI-MRD) predicts poor outcomes in B-lineage acute lymphoblastic leukemia (B-ALL). While MRD positivity is conventionally defined at ≥0.01%, data regarding the prognostic relevance of flow cytometry derived EOI-MRD of <0.01% are emerging. Consecutive pediatric B-ALL patient...

Karthik Bommannan, V. Radhakrishnan, S. Sundersingh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.